Terms ending in 2037
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,323,028 | 1,3,4-Thiadiazole Compounds and Their Use in Treating Cancer In force · High confidence | Cancer Research Technology Limited | In force | High confidence | |
| US 11,753,405 | 1,3,4-Thiadiazole Compounds and Their Use in Treating Cancer In force · High confidence | AstraZeneca AB and Cancer Research Technology Limited | In force | High confidence | |
| US 10,894,789 | Halo-Substituted Piperidines as Orexin Receptor Modulators In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 11,434,236 | Halo-Substituted Piperidines as Orexin Receptor Modulators In force · High confidence | Niuvera Bio, Inc. | In force | High confidence | |
| US 10,407,404 | Physical Form of a SGR Modulator In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,125,135 | Chemical Compounds Grace period ended Nov 13, 2026 · lapse expected · Low confidence | AstraZeneca UK Limited | Grace period ended Nov 13, 2026 lapse expected | Low confidence | |
| US 10,729,655 | Orally Disintegrating Tablets In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,840,518 | MCL-1 Inhibitors and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,196,404 | MCL-1 Inhibitors and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 10,889,594 | MCL-1 Inhibitors and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| 14 more term ends in 2037 · Pro | |||||
10 of 24 patents shown. Soonest term end first, then patent number.
Pro members see all 24.
21 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.